ANI-Guided Anesthetic Desflurane Consumption
NCT: NCT06982209 · COMPLETED
Brief Summary
General anesthesia requires precise titration of inhaled anesthetics like desflurane and opioids like remifentanil to balance sedation, analgesia, and hemodynamic stability. The Analgesia/Nociception Index (ANI), derived from heart rate variability (HRV), quantifies parasympathetic tone to assess nociception-antinociception balance on a 0-100 scale, with lower values indicating nociceptive stress. ANI analyzes high-frequency HRV components, reflecting parasympathetic inhibition during painful stimuli, making it a reliable indicator of intraoperative nociception. Studies validate the utility of ANI in detecting nociceptive events during laparoscopic surgery. ANI-guided opioid titration reduces opioid consumption and stabilizes hemodynamics, enhancing perioperative outcomes.
Frequently Asked Questions
What is ANI-Guided Anesthetic Desflurane Consumption?
ANI-Guided Anesthetic Desflurane Consumption is a clinical trial registered under NCT06982209. Current status: COMPLETED.
What is the status of NCT06982209?
The current status of NCT06982209 (ANI-Guided Anesthetic Desflurane Consumption) is: COMPLETED.
When did ANI-Guided Anesthetic Desflurane Consumption start?
ANI-Guided Anesthetic Desflurane Consumption started on 2026-07-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.